A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-988 in Healthy Participants
Stopped The study stopped early, before enrolling its first participant.
Conditions
Interventions
- DRUG: TAK-988
- DRUG: TAK-988 Placebo
Sponsor
Takeda